COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
Mário Roberto SengerTereza Cristina Santos EvangelistaRafael Ferreira DantasMarcos V. SantanaLuiz Carlos Saramago GonçalvesLauro Ribeiro de Souza NetoSabrina Baptista FerreiraFloriano Paes Silva
Abstract
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infection that may break the healthcare system of several countries. Here, we aimed at presenting a critical view of ongoing drug repurposing efforts for COVID-19 as well as discussing opportunities for development of new treatments based on current knowledge of the mechanism of infection and potential targets within. Finally, we also discuss patent protection issues, cost effectiveness and scalability of synthetic routes for some of the most studied repurposing candidates since these are key aspects to meet global demand for COVID-19 treatment.
Metrics
Citation History
Topics
Related Documents
Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
Drug discovery for COVID-19 treatment based on drug targets
Drug Repurposing and Computational Drug Discovery for Viral Infections and COVID-19
M. V. ManoharAmogha G. PaladhiBhoomika InamdarKotthapalli PrashanthSugumari VallinayagamMithun Rudrapal
Discovery of new drug indications for COVID-19: A drug repurposing approach
Priyanka KumariBikram PradhanMaria KorominaGeorge P. PatrinosKristel Van Steen